Advanced Ultrasound in Diagnosis and Therapy ›› 2024, Vol. 8 ›› Issue (1): 22-28.doi: 10.37015/AUDT.2024.230044
• Original Research • Previous Articles Next Articles
Yuqing Huang, MDa, Cui Lei, BSb(
), Xinyu Zhao, PhDc, Jing Xiao, PhDd, Xian-Quan Shi, PhDa,*
Received:2023-07-30
Accepted:2023-09-28
Online:2024-03-30
Published:2024-02-04
Contact:
Department of Ultrasound, Beijing Friendbship Hospital, Capital Medical University, 95 Yong An Road, Beijing, China.e-mail: Yuqing Huang, MD, Cui Lei, BS, Xinyu Zhao, PhD, Jing Xiao, PhD, Xian-Quan Shi, PhD. Identification of Differently Expressed miRNAs and Genes between Benign Prostatic Hyperplasia and Prostate Cancer. Advanced Ultrasound in Diagnosis and Therapy, 2024, 8(1): 22-28.
Table 1
The top ten DEmiRNAs between benign prostatic hyperplasia and prostate cancer"
| DEmiRNAs | baseMean | log2FC | lfcSE | stat | p-value | Padj |
|---|---|---|---|---|---|---|
| hsa-miR-7706 | 43.74332 | 2.646137 | 0.413391 | 6.401056 | 1.54E-10 | 2.96E-08 |
| hsa-miR-210-3p | 206.0853 | 2.554497 | 0.410772 | 6.218768 | 5.01E-10 | 4.89E-08 |
| hsa-miR-324-3p | 40.06085 | 2.457721 | 0.436168 | 5.634801 | 1.75E-08 | 1.14E-06 |
| hsa-miR-1180-3p | 46.64679 | 2.154102 | 0.42419 | 5.078148 | 3.81E-07 | 1.31E-05 |
| hsa-miR-296-5p | 5.398728 | 2.470078 | 0.493403 | 5.00621 | 5.55E-07 | 1.62E-05 |
| hsa-miR-3615 | 301.8162 | 2.135752 | 0.430592 | 4.960039 | 7.05E-07 | 1.79E-05 |
| hsa-miR-1306-3p | 5.838892 | 2.009393 | 0.409355 | 4.908687 | 9.17E-07 | 2.23E-05 |
| hsa-miR-636 | 10.91144 | 2.739224 | 0.581551 | 4.710204 | 2.47E-06 | 5.04E-05 |
| hsa-miR-339-3p | 115.3661 | 2.049528 | 0.437868 | 4.680703 | 2.86E-06 | 5.40E-05 |
| hsa-miR-3200-3p | 3.870076 | 2.358303 | 0.516304 | 4.567666 | 4.93E-06 | 8.49E-05 |
| [1] |
Kim EH, JA Larson, and GL Andriole. Management of benign prostatic hyperplasia. Annu Rev Med 2016; 67:137-151.
doi: 10.1146/annurev-med-063014-123902 pmid: 26331999 |
| [2] |
Zhu C, DQ Wang, H Zi, Q Huang, JM Gu, LY Li, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res 2021; 8:64.
doi: 10.1186/s40779-021-00359-8 pmid: 34879880 |
| [3] | Chen J, D Zhang, W Yan, D Yang, and B Shen. Translational bioinformatics for diagnostic and prognostic prediction of prostate cancer in the next-generation sequencing era . Biomed Res Int 2013;901578. |
| [4] | Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008; 20 Suppl 3:S11-18. |
| [5] |
McNeal JE, EA Redwine, FS Freiha, and TA Stamey. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12:897-906.
doi: 10.1097/00000478-198812000-00001 pmid: 3202246 |
| [6] | Institute, NC. Understanding prostate changes: a health guide for men. https://www.cancer.gov/types/prostate/understanding-prostate-changes. |
| [7] |
Sommers SC. Endocrine changes with prostatic carcinoma. Cancer 1957; 10:345-358.
pmid: 13426991 |
| [8] |
Bostwick DG, WH Cooner, L Denis, GW Jones, PT Scardino, and GP Murphy, The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992; 70:291-301.
doi: 10.1002/1097-0142(19920701)70:1+<291::aid-cncr2820701317>3.0.co;2-4 pmid: 1376199 |
| [9] |
Tanaka T, T Koie, C Ohyama, Y Hashimoto, A Imai, Y Tobisawa, et al. Incidental prostate cancer in patients with muscle-invasive bladder cancer who underwent radical cystoprostatectomy. Jpn J Clin Oncol 2017; 47:1078-1082.
doi: 10.1093/jjco/hyx119 pmid: 28973396 |
| [10] |
JY Joung, SO Yang, HK Seo, TS Kim, KS Han, J.Chung, et al. Incidental prostate cancer detected by cystoprostatectomy in Korean men. Urology 2009; 73:153-157.
doi: 10.1016/j.urology.2008.02.040 pmid: 18407328 |
| [11] |
He B, Z Zhao, Q Cai, Y Zhang, P Zhang, S Shi, et al. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci 2020; 16:2628-2647.
doi: 10.7150/ijbs.47203 pmid: 32792861 |
| [12] |
Greco F, A Inferrera, R La Rocca, M Navarra, M Casciaro, G Grosso, et al. The potential role of microRNAs as biomarkers in benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol Focus 2019; 5:497-507.
doi: S2405-4569(18)30009-9 pmid: 29398458 |
| [13] |
Macedo Hair G, F Fonseca Nobre, and P Brasil. Characterization of clinical patterns of dengue patients using an unsupervised machine learning approach. BMC Infect Dis 2019; 19:649.
doi: 10.1186/s12879-019-4282-y pmid: 31331271 |
| [14] |
Yan J, L Liu, W Wang, Y Zhao, KK Li, K Li, et al. Radiomic features from multi-parameter MRI combined with clinical parameters predict molecular subgroups in patients with medulloblastoma. Front Oncol 2020; 10:558162.
doi: 10.3389/fonc.2020.558162 |
| [15] |
De Nunzio C, S Ahyai, R Autorino, A Bachmann, W Bialek, A Briganti, et al. Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities. Eur Urol 2011; 60:1205-1206.
doi: 10.1016/j.eururo.2011.08.055 pmid: 21930341 |
| [16] |
Langan RC, Benign prostatic hyperplasia. Prim Care 2019; 46:223-232.
doi: S0095-4543(19)30006-5 pmid: 31030823 |
| [17] |
Wang S, Q Mao, Y Lin, J Wu, X Wang, X Zheng, et al. Body mass index and risk of BPH: a meta-analysis. Prostate Cancer Prostatic Dis 2012; 15:265-272.
doi: 10.1038/pcan.2011.65 |
| [18] |
Wang YB, L Yang, YQ Deng, SY Yan, LS Luo, P Chen, et al. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study. J Transl Med 2022; 20:495.
doi: 10.1186/s12967-022-03722-y |
| [19] | Li BH, T Deng, Q Huang, H Zi, H Weng, and XT Zeng. Body mass index and risk of prostate volume, international prostate symptom score, maximum urinary flow rate, and post-void residual in benign prostatic hyperplasia patients. Am J Mens Health 2019; 13:1557988319870382. |
| [20] | Parsons JK, AV Sarma, K McVary, and JT Wei. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol 2009; 182:S27-S31. |
| [21] |
Kabekkodu SP, V Shukla, VK Varghese, DS J, S Chakrabarty, and K Satyamoorthy. Clustered miRNAs and their role in biological functions and diseases. Biol Rev Camb Philos Soc 2018; 93:1955-1986.
doi: 10.1111/brv.12428 pmid: 29797774 |
| [22] |
Zhang N, Z Li, F Bai, N Ji, Y Zheng, Y Li, et al. MicroRNA expression profiles in benign prostatic hyperplasia. Mol Med Rep 2018; 17:3853-3858.
doi: 10.3892/mmr.2017.8318 pmid: 29359788 |
| [23] |
Cochetti G, G Poli, G Guelfi, A Boni, MG Egidi, and E Mearini. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role. Onco Targets Ther 2016; 9:7545-7553.
doi: 10.2147/OTT |
| [1] | Mohammed Amr, Machado Priscilla, Siu Xiao Tania, Tahmasebi Aylin, Alnoury Mostafa, Trabulsi Edouard, J. Halpern Ethan, R. Eisenbrey John, Forsberg Flemming. Precision Imaging for Prostate Cancer Localization: How Multiparametric Ultrasound Stands Against Multiparametric MRI [J]. Advanced Ultrasound in Diagnosis and Therapy, 2024, 8(4): 217-230. |
| [2] | Ruiqing Liu, MD, Yaqiong Li, PhD, Bing Mao, MD, Na Li, PhD, Shaobo Duan, MD, Zhiyang Chang, MS, Ye Zhang, MS, Shuaiyang Wang, MS, Lianzhong Zhang, MD. Focal Ablation Therapy for Prostate Cancer: A Literature Review [J]. Advanced Ultrasound in Diagnosis and Therapy, 2020, 4(4): 308-314. |
| [3] | Lixue Zhai, MD, Xiaojuan Zhang, MD, Yuxiu Gao, MD, Zhaoyan Ding, MD, Haiyang Yu, MD, Cheng Zhao, MD. Progress in Imaging Diagnosis and Image-guided Puncture Biopsy of Prostate Cancer [J]. Advanced Ultrasound in Diagnosis and Therapy, 2019, 3(4): 175-181. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
Share: WeChat
Copyright ©2018 Advanced Ultrasound in Diagnosis and Therapy
|
Advanced Ultrasound in Diagnosis and Therapy (AUDT) a>
is licensed under a Creative Commons Attribution 4.0 International License a>.
